Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kim Monkhorst

19PUBLICATIONS

157CO-AUTHORS

Cancer geneticsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Apr 02, 2026

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Jeffrey van Putten, Petur Snaebjornsson, Linda J W Bosch

|Mar 21, 2026

Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Jeffrey van Putten, Petur Snaebjornsson, Linda J W Bosch

|Oct 01, 2025

Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol.

Karlijn Verkerk, Soemeya F Haj Mohammad, Laurien J Zeverijn

|Apr 15, 2025

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

Milou M F Schuurbiers, Christopher G Smith, Koen J Hartemink

|Feb 12, 2025

Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape Project.

Martina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou

|Jan 17, 2025

Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial.

Michiel M Smeenk, Judi N A van Diessen, Thierry N Boellaard

Pageof 4

Frequent Collaborators

5 joint publications

Michel M van den Heuvel

5 joint publications

Egbert Smit

4 joint publications

Vincent van der Noort

4 joint publications

Karlijn Hummelink

3 joint publications

Edwin Cuppen

3 joint publications

Joachim G J V Aerts

3 joint publications

Willemijn S M E Theelen

3 joint publications

Koen J Hartemink

3 joint publications

Emile E Voest

2 joint publications

Daan C L Vessies

Frequent Collaborators

5 joint publications

Michel M van den Heuvel

5 joint publications

Egbert Smit

4 joint publications

Vincent van der Noort

4 joint publications

Karlijn Hummelink

Top Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on : Nov 05, 2019

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on : Nov 05, 2019

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos